| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2553117 | Life Sciences | 2008 | 7 Pages |
Abstract
Our results indicated that p53 activation mediated cisplatin-induced RTC death through upregulation of Puma, and suggested that inhibition of p53 and Puma is beneficial for the prevention and treatment of cisplatin-induced acute renal failure.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kazuhiko Tsuruya, Hideki Yotsueda, Hirofumi Ikeda, Masatomo Taniguchi, Kohsuke Masutani, Hideko Hayashida, Hideki Hirakata, Mitsuo Iida,